Archive | News RSS feed for this section

Investment in G&H Orthodontics

Altaris Capital Partners, LLC (“Altaris”) announces an investment in G&H Orthodontics. G&H Orthodontics is a global designer, manufacturer and distributor of clinical orthodontia products. Headquartered in Franklin, IN, G&H sells a full suite of American-made orthodontic brackets, bands, tubes, wires, springs, elastomerics and other dental consumables to customers in more than 90 countries. www.ghorthodontics.com Altaris […]

Recapitalization of AGS Health

Altaris Capital Partners, LLC (“Altaris”) recapitalizes AGS Health in partnership with its founder, Devendra Saharia, and existing shareholder, MTS Health Investors, LLC. About AGS Health AGS Health is a provider of outsourced revenue cycle management services to U.S.-based healthcare providers and billing companies.  The Company’s services include accounts receivable management, medical coding and transaction processing. […]

Minnetronix Maintains Perfect Record with Seventh FDA Inspection

Minnetronix, maintaining our perfect record, has now undergone seven successful FDA Quality System Inspection Technique (QSIT) inspections with No Action Indicated (2017, 2016, 2015, 2010, 2008, 2004 and 2001). We achieved this milestone by continually assessing and improving our Quality Management System (QMS). In a typical year, our system is subjected to more than 30 […]

CSafe Offers Cool Chain Solutions to Hurricane Harvey Disaster Relief Agencies

Quick and efficient disaster response and emergency management can be ensured through the use of thermally insulated boxes and actively powered shipping containers which protect temperature critical medical supplies due to extended hold times during catastrophic conditions. CSafe Global, the world’s leading expert in cold chain solutions, producing actively controlled mobile refrigeration units for life […]

CMP Pharma Announces FDA Approval of CaroSpir® (Spironolactone Oral Suspension, 25mg/5mL)

CMP Pharma announced that the US Food and Drug Administration (FDA) has granted final approval of the company’s New Drug Application (NDA) for CaroSpir® (Spironolactone Oral Suspension, 25 mg/5mL), the first and only FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone. “CaroSpir® provides a stable, ready to use and consistent liquid treatment option […]